Mergers & Acquisitions - USA

Filter

Current filters:

USA

Popular Filters

1 to 25 of 64 results

Roche enters NIPT sector with acquisition of Ariosa Diagnostics

Roche enters NIPT sector with acquisition of Ariosa Diagnostics

03-12-2014

Swiss pharma major Roche has acquired Ariosa Diagnostics, a privately-held company based in San Jose,…

Ariosa DiagnosticsMergers & AcquisitionsPharmaceuticalRocheUSAWomen's Health

Otsuka acquires Avanir for $3.5 billion

Otsuka acquires Avanir for $3.5 billion

02-12-2014

The US subsidiary of Japanese drug maker Otsuka has acquired US CNS specialist Avanir Pharmaceuticals…

AvanirJapanMergers & AcquisitionsNeurologicalNuedextaOtsuka PharmaceuticalPharmaceuticalUSA

FTC puts conditions on GSK/Novartis consumer JV

27-11-2014

The US Federal Trade Commission has voted to approve UK pharma giant GlaxoSmithKline’s proposed acquisition…

Dr Reddy's LaboratoriesGlaxoSmithKlineHabitrolMergers & AcquisitionsNicodermNovartisPharmaceuticalRegulationUSAVaccines

Apellis Pharma to acquire former parent Potentia

Apellis Pharma to acquire former parent Potentia

26-11-2014

USA-based Apellis Pharmaceuticals has entered into an agreement to acquire Potentia Pharmaceuticals,…

Apellis PharmaceuticalsMergers & AcquisitionsOphthalmicsPharmaceuticalPotentia PharmaceuticalsUSA

Allergan agrees to $66 billion acquisition by Actavis

Allergan agrees to $66 billion acquisition by Actavis

17-11-2014

Confirming what were becoming ever stronger rumors over the weekend, Ireland-headquartered Actavis this…

ActavisAllerganMergers & AcquisitionsPharmaceuticalUSAValeant Pharmaceuticals International

Valeant buys NicOx’ US ophthalmic diagnostics unit

17-11-2014

Ophthalmology-focused French biotech firm NicOx says that Canada’s Valeant Pharmaceuticals International…

BiotechnologyMergers & AcquisitionsNicOxOphthalmicsUSAValeant Pharmaceuticals InternationalVesneo

Allergan is reportedly in takeover talks with Actavis

Allergan is reportedly in takeover talks with Actavis

07-11-2014

Botox maker Allergan is reportedly in merger talks with Ireland-headquartered generics major Actavis,…

ActavisAllerganMergers & AcquisitionsPharmaceuticalUSA

Mylan and Abbott amend terms of their $5.3 billion deal

Mylan and Abbott amend terms of their $5.3 billion deal

23-10-2014

US generic drugmaker Mylan and US drugmaker Abbott Laboratories have revised the pricing terms of their…

AbbottAbbott LaboratoriesGenericsMergers & AcquisitionsUSA

AbbVie board withdraws bid to acquire Shire

AbbVie board withdraws bid to acquire Shire

16-10-2014

Following takeover target Shire’s waiver of the three-day notice period, AbbVie said this morning that…

AbbVieIrelandMergers & AcquisitionsPharmaceuticalShireUSA

Impax Labs goes on a $700 million buying spree

Impax Labs goes on a $700 million buying spree

09-10-2014

US generic drugmaker Impax Laboratories saw its shares leap 11.2% to $26.52 in pre-market trading today,…

Amedra PharmaceuticalsCorePharmaGenericsImpax LaboratoriesLineage TherapeuticsMergers & AcquisitionsTaiwanUSA

Auxilium Pharma succumbs to higher, $2.6 billion, offer from Endo

Auxilium Pharma succumbs to higher, $2.6 billion, offer from Endo

09-10-2014

Having previously rejected a $28.10 a share takeover offer from Ireland-headquartered Endo International,…

Auxilium PharmaceuticalsEndo InternationalIrelandMen's HealthMergers & AcquisitionsPharmaceuticalQLTUSA

Parexel expands in trial supply management with ClinIntel acquisition

Parexel expands in trial supply management with ClinIntel acquisition

03-10-2014

USA-headquartered biopharma services group Parexel International has acquired all of the outstanding…

Business FinanceClinIntelMergers & AcquisitionsParexel InternationalPharmaceuticalUKUSA

Salix terminates merger with Cosmo, now allegedly seeking deal with Actavis

Salix terminates merger with Cosmo, now allegedly seeking deal with Actavis

03-10-2014

Gastrointestinal specialist Salix Pharmaceuticals is reportedly seeking a deal with Ireland-headquartered…

ActavisCosmo PharmaceuticalsGastro-intestinalsIrelandMergers & AcquisitionsPharmaceuticalSalixUSA

Sigma-Aldrich acquires Cell Marque to grow antibody portfolio

Sigma-Aldrich acquires Cell Marque to grow antibody portfolio

03-10-2014

USA-based life sciences company Sigma-Aldrich has entered into an agreement to acquire US antibody company…

AnatomyBiologyBiotechnologyImmunologicalsMergers & AcquisitionsProtein methodsSigma-AldrichUSA

Islet Sciences announces merger with Brighthaven Ventures

Islet Sciences announces merger with Brighthaven Ventures

01-10-2014

Metabolic biopharma specialist Islet Sciences has announced a merger with Brighthaven Ventures, a privately-held…

Islet SciencesMergers & AcquisitionsNephrology and HepatologyPharmaceuticalremogliflozinUSA

Johnson & Johnson to acquire Alios BioPharma

Johnson & Johnson to acquire Alios BioPharma

30-09-2014

US health care giant Johnson & Johnson has signed a definitive agreement to acquire Alios BioPharma,…

AL-8176Alios BioPharmaAnti-viralsJohnson & JohnsonMergers & AcquisitionsPharmaceuticalUSA

Perrigo sells some preclinical assets to Imago

Perrigo sells some preclinical assets to Imago

29-09-2014

US heath care firm Perrigo says it has transferred a portfolio of preclinical research assets, which…

Imago PharmaceuticalsMergers & AcquisitionsNeurologicalPerrigoPharmaceuticalUSA

Horizon Discovery acquires Sage Labs for $48 million

Horizon Discovery acquires Sage Labs for $48 million

29-09-2014

UK-based Horizon Discovery Group has agreed to acquire Sage Labs of the USA for up to $16 million in…

GeneticsHorizon DiscoveryMergers & AcquisitionsPharmaceuticalSage LabsUKUSA

Actavis approached by Pfizer in latest takeover deal, according to sources

Actavis approached by Pfizer in latest takeover deal, according to sources

24-09-2014

US pharma giant Pfizer has held talks regarding an acquisition of Ireland-headquartered generics major…

ActavisMergers & AcquisitionsPfizerPharmaceuticalUSA

NovaDel sells ZolpiMist NDA, license and IP to Amherst Pharma

23-09-2014

NovaDel Pharma has sold its insomnia drug ZolpiMist (zolpidem oral spray) New Drug Application to fellow…

Amherst PharmaceuticalsMergers & AcquisitionsNeurologicalNovaDel PharmaPharmaceuticalUSAZolpiMist

US Treasury to crack down on tax inversion M&A deals

US Treasury to crack down on tax inversion M&A deals

23-09-2014

The USA’s Department of the Treasury announced on Monday that it is taking action to reduce the tax…

FinancialMergers & AcquisitionsPharmaceuticalPoliticsUSA

1 to 25 of 64 results

Back to top